Brind.
  1. Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.
  2. Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.
  3. Trump-era tariffs may benefit AI stocks, while Google faces DOJ rulings and secures a default search engine deal with Apple.
  4. AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.

Trump-era tariffs are benefiting AI stocks, and the FDA expanded the patient base for WAKIX.

15 reports, 3 independent Updated Aug 29
Gone quiet Reached 3 outlets in its first 24 hours
Reports
15
Developments
11
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Trump-era tariffs are benefiting AI stocks, and the FDA expanded the patient base for WAKIX.

Who's involved

What this event is mainly about
Donald TrumpInvestAvanos Medical

How it developed

Newest first. Tap a step to see who reported it.
  1. BP-205 pipeline offers future growth potential, and WAKIX revenue drives company financial performance.Sub-event
  2. Trump-era tariffs benefit certain AI stocks, and Aptevo Therapeutics regained compliance with Nasdaq listing rules.Sub-event
  3. MaxCyte licensed its platform technology to Adicet Bio, Inc. for cell therapies, amid reports that Trump-era tariffs benefit AI stocks.Sub-event
  4. Wells Fargo raised its price target on Teneable Holdings, citing benefits from Trump-era tariffs and onshoring trends.Sub-event
  5. Harmony Biosciences Holdings, Inc. presented company data at a congress held in Lisbon, Portugal, on August 26, 2025.Sub-event
  6. Tariffs and onshoring trends are benefiting AI stocks, while a company acquisition enhances its liver disease portfolio, aided by a breakthrough designation.Sub-event
  7. FDA approval is cited as the driver of stock momentum for AI companies benefiting from Trump-era policies.1 source
  8. TD Cowen maintains Buy ratings on Amicus Therapeutics.1 source
Show 3 earlier steps
  1. AI stocks benefit from tariffs, and FDA expanded WAKIX patient base.1 source
  2. Trump-era tariffs benefit certain AI stocks.1 source
  3. Avanos Medical is noted as benefiting from Trump-era tariffs on AI stocks.1 source

Keep exploring

Part of

AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.

Also in this story

All 32 developments

Within Major tech companies like Microsoft, Google, Amazon, and OpenAI are heavily investing in and competing within the AI revolution.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyTeva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVY We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Teva Pharmaceutical Indu
  • Insider MonkeyAmicus Therapeutics, Inc. (FOLD) Expands Pipeline With Rare Kidney Disease Drug We recently published 10 Best Biotech Stocks to Buy Under $10. Amicus Therapeutics, Inc. is one of them. Amicus Therape
  • Insider MonkeyJ.P. Morgan Raises the PT on Ionis Pharmaceuticals (IONS), Keeps a Hold Rating Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the Best Mid Cap Growth Stocks to Buy According to Hedge Funds. On A
  • Insider MonkeyHarmony Biosciences Holdings, Inc. (HRMY) Expands WAKIX With FDA Nod for Prader-Willi We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Harmony Biosciences H
  • Insider MonkeyTD Cowen Upgrades EPAM Systems, Inc. (EPAM) from ‘Hold’ to ‘Buy’ Amid Improved Revenue Momentum EPAM Systems, Inc. (NYSE:EPAM) is one of the 12 Best Stocks to Buy in Falling Markets According to Hedg
  • Insider MonkeyRegulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company’s stoc
  • Insider MonkeyH.C. Wainwright Remains a Buy on Harmony Biosciences Holdings (HRMY) Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the top most undervalued biotech stocks to buy now. H.C. Wainwright ana
  • Insider MonkeyHarmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on In. Specter’s Substack. In this article, we will summarize the b
  • Business WireHarmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 WAKIX® (pito
  • Simply Wall St.Stryker (SYK) Raises Guidance As Sales Reach US$6 Billion In Strong Q2 Stryker has raised its earnings guidance for 2025, citing strong product demand and operational momentum, following a reported 1
  • Insider MonkeyAGNC Investment (AGNC)’s Outlook for Agency MBS Remains Favorable AGNC Investment Corp. (NASDAQ:AGNC) is one of the Most Undervalued Stocks Under $10 to Buy Now. In Q1 2025, the prospects of potentia
  • Insider MonkeyAvanos Medical (AVNS) Appoints Camille Chang Gilmore as SVP and Chief Human Resources Officer Avanos Medical, Inc. (NYSE:AVNS) is one of the best undervalued medical device stocks to buy now. On June
  • Insider MonkeyTD Cowen Remains Bullish on Amicus Therapeutics (FOLD) With a $20 PT Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 1, analyst Ritu Baral fro
  • Insider MonkeyH.C. Wainwright Remains Bullish on Harmony Biosciences Holdings (HRMY) Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 30
  • Unknown outlet